Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma.

Sebastian E SerflingYingjun ZhiFelix MegerleMartin FassnachtAndreas K BuckConstantin LapaRudolf A Werner

Published in: Endocrine (2022)

In patients with MTC, SSTR-PET/CT was superior to CT alone and provided relevant support in therapeutic decision-making in more than two thirds of cases, with most patients being switched to surgical interventions or systemic treatment with TKI. As such, SSTR-PET/CT can guide the referring treating physician towards disease-directed treatment in various clinical scenarios.

Keyphrases

pet ct
positron emission tomography
end stage renal disease
emergency department
primary care
computed tomography
newly diagnosed
ejection fraction
chronic kidney disease
climate change
tyrosine kinase
advanced non small cell lung cancer
epidermal growth factor receptor
drug induced
dual energy